Unilever Grows European Portfolio, P&G Trims More Brands In Toothpaste Deal
Executive Summary
Fluocaril and Parogencyl are “well-known” toothpastes that have garnered “strong endorsement from health professionals,” Unilever says. The brands, identified by analysts as potential candidates for sale, are latest in P&G’s ongoing trimming of lower-selling lines.
You may also be interested in...
P&G Raises Guidance On Strong Q1 With Analysts Anticipating Headwinds
Net and organic sales up 7% to $17.8bn in its FY 2020 Q1 as its turnaround takes hold and pricing increases it implemented a year ago push revenues. CFO Jon Moeller says P&G revises guidance upwards for FY2020 and is better positioned to counter potential recession headwinds than it was in 2008.
P&G’s Gamble To Hike Prices Pays Off With 4% Net Sales Growth In Q4
For the final quarter of its FY19, P&G reports 4% net sales growth to $17.1bn. Pricing and organic volume each contributed 3 percentage points to organic sales growth in the firm's strongest quarter since before the US financial crisis in 2008.
Unilever Q1: Aggressive M&A Paying Off; Oral Care Cited As Space To ‘Watch’
Anglo-Dutch firm’s prestige business, created in recent years through acquisitions such as Hourglass, Dermalogica and Kate Sommerville, grew by double digits in the first quarter. Oral care declined, but CEO Alan Jope is optimistic about the segment’s future.